{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T01:34:15Z","timestamp":1788572055244,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,5,6]],"date-time":"2012-05-06T00:00:00Z","timestamp":1336262400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Appl Microbiol Biotechnol"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1007\/s00253-012-4100-6","type":"journal-article","created":{"date-parts":[[2012,5,5]],"date-time":"2012-05-05T09:05:16Z","timestamp":1336208716000},"page":"1179-1189","source":"Crossref","is-referenced-by-count":10,"title":["Development of a pilot-scale production process and characterization of a recombinant Japanese encephalitis virus envelope domain III protein expressed in Escherichia coli"],"prefix":"10.1007","volume":"95","author":[{"given":"Nagesh K.","family":"Tripathi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambuj","family":"Shrivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karttik C.","family":"Biswal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. V. Lakshmana","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,5,6]]},"reference":[{"key":"4100_CR1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00430-007-0043-4","volume":"196","author":"BK Alka","year":"2007","unstructured":"Alka Bharati K, Malik YPS, Vrati S (2007) Immunogenicity and protective efficacy of the E. coli expressed domain III of Japanese encephalitis virus envelope protein in mice. Med Microbiol Immunol 196:227\u2013231","journal-title":"Med Microbiol Immunol"},{"key":"4100_CR2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jviromet.2009.07.002","volume":"162","author":"MB Appaiahgari","year":"2009","unstructured":"Appaiahgari MB, Abdin MZ, Bansal KC, Vrati S (2009) Expression of Japanese encephalitis virus envelope protein in transgenic tobacco plants. J Virol Methods 162:22\u201329","journal-title":"J Virol Methods"},{"key":"4100_CR3","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1007\/s12010-009-8718-5","volume":"160","author":"V Babaeipour","year":"2010","unstructured":"Babaeipour V, Shojaosadati SA, Khalilzadeh R, Maghsoudi N, Farnoud AM (2010) Enhancement of human gamma-interferon production in recombinant E. coli using batch cultivation. Appl Biochem Biotechnol 160:2366\u20132376","journal-title":"Appl Biochem Biotechnol"},{"key":"4100_CR4","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1016\/j.vaccine.2008.07.006","volume":"26","author":"JP Babu","year":"2008","unstructured":"Babu JP, Pattnaik P, Gupta N, Shrivastava A, Khan M, Rao PVL (2008) Immunogenicity of a recombinant envelope domain III protein of dengue virus type-4 with various adjuvants in mice. Vaccine 26:4655\u20134663","journal-title":"Vaccine"},{"key":"4100_CR5","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.vaccine.2008.12.027","volume":"27","author":"BA Bell","year":"2009","unstructured":"Bell BA, Wood JF, Bansal R, Ragab H, Cargo J III, Washington MA, Wood CL, Ware LA, Ockenhouse CF, Yadava A (2009) Process development for the production of an E. coli produced clinical grade recombinant malaria vaccine for Plasmodium vivax. Vaccine 27:1448\u20131453","journal-title":"Vaccine"},{"key":"4100_CR6","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1586\/14787210.4.2.313","volume":"4","author":"K Bharati","year":"2006","unstructured":"Bharati K, Vrati S (2006) Japanese encephalitis: development of new candidate vaccines. Expert Rev Anti Infect Ther 4:313\u2013324","journal-title":"Expert Rev Anti Infect Ther"},{"key":"4100_CR7","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s10295-010-0753-2","volume":"37","author":"S Bhuvanesh","year":"2010","unstructured":"Bhuvanesh S, Arunkumar C, Kaliraj P, Ramalingam S (2010) Production and single-step purification of Brugia malayi abundant larval transcript (ALT-2) using hydrophobic interaction chromatography. J Ind Microbiol Biotechnol 37:1053\u20131059","journal-title":"J Ind Microbiol Biotechnol"},{"key":"4100_CR8","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1038\/nm1218","volume":"11","author":"BC Buckland","year":"2005","unstructured":"Buckland BC (2005) The process development challenge for a new vaccine. Nat Med 11:S16\u2013S19","journal-title":"Nat Med"},{"key":"4100_CR9","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0264-410X(96)00183-1","volume":"15","author":"JC Cox","year":"1997","unstructured":"Cox JC, Coulter AR (1997) Adjuvants\u2014a classification and review of their modes of action. Vaccine 15:248\u2013256","journal-title":"Vaccine"},{"key":"4100_CR10","first-page":"1","volume":"59","author":"M Fischer","year":"2010","unstructured":"Fischer M, Lindsey N, Staples JE, Hills S (2010) Japanese encephalitis vaccines recommendations of the advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 59:1\u201326","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"4100_CR11","doi-asserted-by":"crossref","first-page":"e12279","DOI":"10.1371\/journal.pone.0012279","volume":"5","author":"MH Huang","year":"2010","unstructured":"Huang MH, Lin SC, Hsiao CH, Chao HJ, Yang HR, Liao CC, Chuang PW, Wu HP, Huang CY, Leng CH, Liu SJ, Chen HW, Chou AH, Hu AY, Chong P (2010) Emulsified nanoparticles containing inactivated influenza virus and CpG oligodeoxynucleotides critically influences the host immune responses in mice. PLoS One 5:e12279","journal-title":"PLoS One"},{"key":"4100_CR12","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1007\/s10295-008-0408-8","volume":"35","author":"R Khalilzadeh","year":"2008","unstructured":"Khalilzadeh R, Mohammadian MJ, Bahrami A, Tabbar AN, Khalili MAN, Amouheidari A (2008) Process development for production of human granulocyte-colony stimulating factor by high cell density cultivation of recombinant Escherichia coli. J Ind Microbiol Biotechnol 35:1643\u20131650","journal-title":"J Ind Microbiol Biotechnol"},{"key":"4100_CR13","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s10295-009-0606-z","volume":"36","author":"M Khamduang","year":"2009","unstructured":"Khamduang M, Packdibamrung K, Chutmanop J, Chisti Y, Srinophakun P (2009) Production of l-phenylalanine from glycerol by a recombinant Escherichia coli. J Ind Microbiol Biotechnol 36:1267\u20131274","journal-title":"J Ind Microbiol Biotechnol"},{"key":"4100_CR14","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1016\/j.vaccine.2009.03.007","volume":"27","author":"JJ Liang","year":"2009","unstructured":"Liang JJ, Liao CL, Liao JT, Lee YL, Lin YL (2009) A Japanese encephalitis virus vaccine candidate strain is attenuated by decreasing its interferon antagonistic ability. Vaccine 27:2746\u20132754","journal-title":"Vaccine"},{"key":"4100_CR15","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s002530050009","volume":"53","author":"HK Lim","year":"2000","unstructured":"Lim HK, Jung KH, Park DH, Chung SI (2000) Production characteristics of interferon-\u03b1 using an l-arabinose promoter system in a high-cell-density culture. Appl Microbiol Biotechnol 53:201\u2013208","journal-title":"Appl Microbiol Biotechnol"},{"key":"4100_CR16","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10529-007-9529-9","volume":"30","author":"CW Lin","year":"2008","unstructured":"Lin CW, Liu KT, Huang HD, Chen WJ (2008) Protective immunity of E. coli-synthesized NS1 protein of Japanese encephalitis virus. Biotechnol Lett 30:205\u2013214","journal-title":"Biotechnol Lett"},{"key":"4100_CR17","first-page":"991","volume-title":"Fields virology","author":"BD Lindenbach","year":"2001","unstructured":"Lindenbach BD, Rice CM (2001) Flaviviridae: the viruses and their replication. In: Knipe DM, Howley PM (eds) Fields virology, 4th edn. Lippincott Williams & Wilkins, Philadelphia, pp 991\u20131041","edition":"4"},{"key":"4100_CR18","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10295-005-0046-3","volume":"33","author":"D Manderson","year":"2006","unstructured":"Manderson D, Dempster R, Chisti Y (2006) Recombinant vaccine against hydatidosis: production of the antigen in Escherichia coli. J Ind Microbiol Biotechnol 33:173\u2013182","journal-title":"J Ind Microbiol Biotechnol"},{"key":"4100_CR19","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s00449-009-0394-x","volume":"33","author":"S Mazumdar","year":"2010","unstructured":"Mazumdar S, Sachdeva S, Chauhan VS, Yazdani SS (2010) Identification of cultivation condition to produce correctly folded form of a malaria vaccine based on Plasmodium falciparum merozoite surface protein-1 in Escherichia coli. Bioprocess Biosyst Eng 33:719\u2013730","journal-title":"Bioprocess Biosyst Eng"},{"key":"4100_CR20","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0889-8561(03)00102-4","volume":"23","author":"AM Plesner","year":"2003","unstructured":"Plesner AM (2003) Allergic reactions to Japanese encephalitis vaccine. Immunol Allergy Clin N Am 23:665\u2013697","journal-title":"Immunol Allergy Clin N Am"},{"key":"4100_CR21","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/infdis\/161.5.878","volume":"161","author":"JD Poland","year":"1990","unstructured":"Poland JD, Cropp CB, Craven RB, Monath TP (1990) Evaluation of the potency and safety of inactivated Japanese encephalitis vaccine in US inhabitants. J Infect Dis 161:878\u2013882","journal-title":"J Infect Dis"},{"key":"4100_CR22","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s00253-006-0673-2","volume":"74","author":"J Sereikaite","year":"2007","unstructured":"Sereikaite J, Statkute A, Morkunas M, Radzevicius K, Borromeo V, Secchi C, Bumelis VA (2007) Production of recombinant mink growth hormone in E. coli. Appl Microbiol Biotechnol 74:316\u2013323","journal-title":"Appl Microbiol Biotechnol"},{"key":"4100_CR23","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jviromet.2009.02.018","volume":"158","author":"J Shukla","year":"2009","unstructured":"Shukla J, Bhargava R, Dash PK, Parida M, Tripathi N, Rao PVL (2009) Cloning and expression of domain III of the envelope gene of Japanese encephalitis virus: evaluation for early clinical diagnosis by IgM ELISA. J Virol Methods 158:165\u2013170","journal-title":"J Virol Methods"},{"key":"4100_CR24","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1263\/jbb.99.303","volume":"99","author":"SM Singh","year":"2005","unstructured":"Singh SM, Panda AK (2005) Solubilization and refolding of bacterial inclusion body proteins. J Biosci Bioeng 99:303\u2013310","journal-title":"J Biosci Bioeng"},{"key":"4100_CR25","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0042-6822(87)90144-9","volume":"161","author":"H Sumiyoshi","year":"1987","unstructured":"Sumiyoshi H, Mori C, Fuke I, Morita K, Kuhara S, Kondou J, Kikuchi Y, Nagamatu H, Igarashi A (1987) Complete nucleotide sequence of the Japanese encephalitis virus genome RNA. Virology 161:497\u2013510","journal-title":"Virology"},{"key":"4100_CR26","doi-asserted-by":"crossref","first-page":"137","DOI":"10.14429\/dsj.59.1501","volume":"59","author":"NK Tripathi","year":"2009","unstructured":"Tripathi NK, Sathyaseelan K, Jana AM, Rao PVL (2009) High yield production of heterologous proteins with Escherichia coli. Def Sci J 59:137\u2013146","journal-title":"Def Sci J"},{"key":"4100_CR27","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1007\/s00253-010-2488-4","volume":"86","author":"NK Tripathi","year":"2010","unstructured":"Tripathi NK, Shukla J, Biswal KC, Rao PVL (2010) Development of a simple fed-batch process for high yield production of Japanese encephalitis virus protein. Appl Microbiol Biotechnol 86:1795\u20131803","journal-title":"Appl Microbiol Biotechnol"},{"key":"4100_CR28","doi-asserted-by":"crossref","first-page":"6905","DOI":"10.1016\/j.vaccine.2009.09.006","volume":"27","author":"SK Verma","year":"2009","unstructured":"Verma SK, Kumar S, Gupta N, Vedic S, Bhattacharya SM, Rao PVL (2009) Bacterially expressed recombinant envelope protein domain III of Japanese encephalitis virus (rJEV-DIII) elicits Th1 type of immune response in BALB\/c mice. Vaccine 27:6905\u20136909","journal-title":"Vaccine"},{"key":"4100_CR29","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bej.2008.09.018","volume":"43","author":"C Wang","year":"2009","unstructured":"Wang C, Wang L, Geng X (2009) Optimization of refolding with simultaneous purification of recombinant human granulocyte colony-stimulating factor from Escherichia coli by immobilized metal ion affinity chromatography. Biochem Eng J 43:197\u2013202","journal-title":"Biochem Eng J"},{"key":"4100_CR30","doi-asserted-by":"crossref","first-page":"46007","DOI":"10.1074\/jbc.M307776200","volume":"278","author":"KP Wu","year":"2003","unstructured":"Wu KP, Wu CW, Tsao YP, Kuo TW, Lou YC, Lin CW, Wu SC, Cheng JW (2003a) Structural basis of a flavivirus recognized by its neutralizing antibody: solution structure of the domain III of the Japanese encephalitis virus envelope protein. J Biol Chem 278:46007\u201346013","journal-title":"J Biol Chem"},{"key":"4100_CR31","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1016\/S0264-410X(03)00042-2","volume":"21","author":"SC Wu","year":"2003","unstructured":"Wu SC, Yu CH, Lin CW, Chu IM (2003b) The domain III fragment of Japanese encephalitis virus envelope protein: mouse immunogenicity and liposome adjuvancity. Vaccine 21:2516\u20131522","journal-title":"Vaccine"},{"key":"4100_CR32","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/bit.260410804","volume":"41","author":"L Yee","year":"1993","unstructured":"Yee L, Blanch HW (1993) Recombinant trypsin production in high cell density fed-batch cultures in Escherichia coli. Biotechnol Bioeng 41:781\u2013790","journal-title":"Biotechnol Bioeng"},{"key":"4100_CR33","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0168-1656(98)00111-4","volume":"64","author":"D Zanette","year":"1998","unstructured":"Zanette D, Dundon W, Soffientini A, Sottani C, Marinelli F, Akeson A, Sarubbi E (1998) Human IL-1 receptor antagonist from Escherichia coli: large-scale microbial growth and protein purification. J Biotechnol 64:187\u2013196","journal-title":"J Biotechnol"}],"container-title":["Applied Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-012-4100-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00253-012-4100-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-012-4100-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T15:22:05Z","timestamp":1558711325000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00253-012-4100-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,6]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["4100"],"URL":"https:\/\/doi.org\/10.1007\/s00253-012-4100-6","relation":{},"ISSN":["0175-7598","1432-0614"],"issn-type":[{"value":"0175-7598","type":"print"},{"value":"1432-0614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,6]]}}}